「Exploring the potential of engineered exosomes as delivery systems for tumor-suppressor microRNA replacement therapy in ovarian cancer」の関連論文
-
Therapeutic potential of combination therapy of soluble VEGF receptor 1 and conventional chemotherapy for ovarian cancer growth
-
Urinary mulberry bodies as a potential biomarker for early diagnosis and efficacy assessment of enzyme replacement therapy in Fabry nephropathy
-
Sleeping Beauty Transposon Mutagenesis Identifies Genes Driving the Initiation and Metastasis of Uterine Leiomyosarcoma
-
The meiosis-specific cohesin component stromal antigen 3 promotes cell migration and chemotherapeutic resistance in colorectal cancer
-
Periostin Short Fragment with Exon 17 via Aberrant Alternative Splicing Is Required for Breast Cancer Growth and Metastasis
-
The CD153 vaccine is a senotherapeutic option for preventing the accumulation of senescent T cells in mice
-
Novel immunotherapy for peritoneal dissemination of murine colon cancer with macrophage inflammatory protein-1β mediated by a tumor-specific vector, HVJ cationic liposomes
-
Early dynamics of circulating tumor DNA predict clinical response to immune checkpoint inhibitors in metastatic renal cell carcinoma
-
Identification of CD14 and lipopolysaccharide-binding protein as novel biomarkers for sarcoidosis using proteomics of serum extracellular vesicles
-
Dysregulated Expression of the Nuclear Exosome Targeting Complex Component Rbm7 in Nonhematopoietic Cells Licenses the Development of Fibrosis
-
Heterogeneity of Treg/Th17 According to Cancer Progression and Modification in Biliary Tract Cancers via Self‑Producing Cytokines
-
Detection of ctDNA with Personalized Molecular Barcode NGS and Its Clinical Significance in Patients with Early Breast Cancer
-
Exosomal CD47 Plays an Essential Role in Immune Evasion in Ovarian Cancer
-
PD-1+ Tim3+ tumor-infiltrating CD8 T cells sustain the potential for IFN-γ production, but lose cytotoxic activity in ovarian cancer
-
Enhanced humoral immunity in breast cancer patients with high serum concentration of anti-HER2 autoantibody
-
Vitamin D Supplementation is a Promising Therapy for Pancreatic Ductal Adenocarcinoma in Conjunction with Current Chemoradiation Therapy
-
Vascular endothelial growth factor-A is an Immunohistochemical biomarker for the efficacy of bevacizumab-containing chemotherapy for duodenal and jejunal adenocarcinoma
-
Tumor-infiltrating M2 macrophage in pretreatment biopsy sample predicts response to chemotherapy and survival in esophageal cancer
-
CD70 antibody-drug conjugate: A potential novel therapeutic agent for ovarian cancer
-
Dipeptidyl Peptidase 9 Increases Chemoresistance and is an Indicator of Poor Prognosis in Colorectal Cancer
-
NOTCH3 limits the epithelial-mesenchymal transition and predicts a favorable clinical outcome in esophageal cancer
-
Targeted therapy for drug-tolerant persister cells after imatinib treatment for gastrointestinal stromal tumours
-
Adeno-associated virus-mediated gene delivery promotes S-phase entry-independent precise targeted integration in cardiomyocytes
-
Potential of Soluble Decellularized Extracellular Matrix for Musculoskeletal Tissue Engineering - Comparison of Various Mesenchymal Tissues
-
Inhibition of glycolytic activator PFKFB3 suppresses tumor growth and induces tumor vessel normalization in hepatocellular carcinoma
-
Evidence that TD-198946 enhances the chondrogenic potential of human synovium-derived stem cells through the NOTCH3 signaling pathway
-
Comparison of the multigene panel test and OncoScan™ for the determination of HER2 amplification in breast cancer
-
Development of Prediction Model Including MicroRNA Expression for Sentinel Lymph Node Metastasis in ER-Positive and HER2-Negative Breast Cancer
-
Immunoscore signatures in surgical specimens and tumor-infiltrating lymphocytes in pretreatment biopsy predict treatment efficacy and survival in esophageal cancer
-
Localization of KRAS downstream target ARL4C to invasive pseudopods accelerates pancreatic cancer cell invasion
-
Local hyperthermia combined with CTLA-4 blockade induces both local and abscopal effects in a murine breast cancer model
-
Circulating tumor HPV DNA complements PET-CT in guiding management after radiotherapy in HPV-related squamous cell carcinoma of the head and neck
-
The potential clinical utility of cell-free DNA for gastric cancer patients treated with nivolumab monotherapy
-
Preclinical Evaluation of Radiation-Induced Toxicity in Targeted Alpha Therapy Using [211At] NaAt in Mice: A Revisit
-
Isolation of tissue-resident endothelial stem cells and their use in regenerative medicine
-
Inhibition of Clusterin Represses Proliferation by Inducing Cellular Senescence in Pancreatic Cancer
-
Inhibition of c-MET reverses radiation-induced malignant potential in pancreatic cancer
-
Periostin Exon-21 Antibody Neutralization of Triple-Negative Breast Cancer Cell-Derived Periostin Regulates Tumor-Associated Macrophage Polarization and Angiogenesis
-
Potency of Tokishakuyakusan in treating preeclampsia:Drug repositioning method by in vitro screening of the Kampo library
-
Enhancement of chondrogenic differentiation supplemented by a novel small compound for chondrocyte-based tissue engineering
-
Heterogenous chemosensitivity of a panel of organoid lines derived from small cell neuroendocrine carcinoma of the uterine cervix
-
The novel immunosuppressant prenylated quinolinecarboxylic acid-18 (PQA-18) suppresses macrophage differentiation and cytotoxicity in xenotransplantation
-
Development and evaluation of a colorectal cancer screening method using machine learning-based gut microbiota analysis
-
Peri-operative monocyte count is a marker of poor prognosis in gastric cancer: increased monocytes are a characteristic of myeloid-derived suppressor cells
-
Signal-transducing adapter protein-1 is required for maintenance of leukemic stem cells in CML
-
Immunotherapeutic potential of CD4 and CD8 single-positive T cells in thymic epithelial tumors
-
Evaluation of HPV16 E7 expression in head and neck carcinoma cell lines and clinical specimens
-
Dihydroouabain, a novel radiosensitizer for cervical cancer identified by automated high-throughput screening
-
An immature inhibin‐α‐expressing subpopulation of ovarian clear cell carcinoma cells is related to an unfavorable prognosis
-
Ectonucleotidase CD39 is highly expressed on ATLL cells and is responsible for their immunosuppressive function